COVID-19 Screening, Diagnosis and Management
Journal of emergency and trauma care is pleased to announce Special issue “COVID-19 Screening, Diagnosis and Management”
Given the nonspecific presentation and current epidemiology (community spread, more common than all other respiratory illnesses), all patients who present with a respiratory illness should presume to have COVID-19 until proven otherwise.
There has been no country that has been able to contain COVID-19, and so attention has turned to “flattening the curve” or slowing down the spread of COVID-19 by widespread screening early in the illness course, social distancing and isolating patients with any symptoms of COVID-19. However, few jurisdictions in North America and Europe have the infrastructure for mass screening and resources (testing kits, staff to perform the screening, contact tracing abilities, and lab capacity) and have been overwhelmed.
At present there is not enough epidemiological data to determine the accuracy/predictive value of the PCR viral swab for COVID-19, however the specificity is thought to be high while the sensitivity is likely <90%. While testing can certainly miss COVID-19 as a result of the relatively poor sensitivity of the PCR viral swab, most of these patients will have a clinical picture that is consistent with COVID-19 and will be presumed to have the diagnosis even with a negative swab result.
With the same purpose our Journal “Journal of emergency and trauma care” is announcing Special issue Call for paper on “COVID-19 Screening, Diagnosis and Management”. We welcome both solicited and unsolicited submissions that will contribute to this special issue.
Submission Process
Please visit Instruction for author’s page to know more about article formatting and guidelines: https://www.imedpub.com/emergency-and-trauma-care/author-guidelines.php